Cite

    Hanada, K. et al. (n.d.). Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens. Journal for immunotherapy of cancer. p. . [Online].